CD8+CD39+ T Cells Mediate Anti-Tumor Cytotoxicity in Bladder Cancer

INTRODUCTION: Although immunotherapy works well in parts of patients with bladder cancer (BLCA), its overall response rate of anti-PD-1 inhibitors remains unsatisfactory. Besides, growing evidence shows that tumor-infiltrating lymphocytes (TILs) immunotherapy has demonstrated excellent efficacy in v...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Wenjie, Zhao, Zihan, Feng, Baofu, Yu, Wenhao, Li, Ji, Guo, Hongqian, Yang, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006912/
https://www.ncbi.nlm.nih.gov/pubmed/33790578
http://dx.doi.org/10.2147/OTT.S297272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006912/
https://www.ncbi.nlm.nih.gov/pubmed/33790578
http://dx.doi.org/10.2147/OTT.S297272

Ejemplares similares